Acadian Asset Management
PACB icon

Acadian Asset Management’s Pacific Biosciences PACB Stock Holding History

Acadian Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$549K Sell
418,791
-22,459
-5% -$40.2K ﹤0.01% 1335
2025
Q4 		$822K Buy
441,250
+418,134
+1,809% +$803K ﹤0.01% 1169
2025
Q3 		$29K Buy
+23,116
New +$31.3K ﹤0.01% 1728
2020
Q3 		– Sell
-128,624
Closed -$444K – 2311
2020
Q2 		$444K Buy
+128,624
New +$438K ﹤0.01% 1235
2017
Q2 		– Sell
-71,084
Closed -$368K – 1545
2017
Q1 		$368K Buy
+71,084
New +$348K ﹤0.01% 949

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return